AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
Detection and quantification of HIV type 1 RNA in nasopharyngeal washes from HIV-infected subjects
Authors: De Souza, MS Trichavaroj, R Sriplienchan, S Buapunth, P Renzullo, PO Chuenchitra, C Birx, DL Robb, ML Brown, AE
Citation: Ms. De Souza et al., Detection and quantification of HIV type 1 RNA in nasopharyngeal washes from HIV-infected subjects, AIDS RES H, 17(3), 2001, pp. 229-232
HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies
Authors: Polonis, VR De Souza, MS Chanbancherd, P Chantakulkij, S Jugsudee, A Loomis-Price, LD Vancott, TC Garner, R Markowitz, LE Brown, AE Birx, DL
Citation: Vr. Polonis et al., HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies, AIDS RES H, 17(1), 2001, pp. 69-79
First CRF01_AE/B recombinant of HIV-1 is found in Thailand
Authors: Tovanabutra, S Polonis, V De Souza, M Trichavaroj, R Chanbancherd, P Kim, B Sanders-Buell, E Nitayaphan, S Brown, A Robb, MR Birx, DL McCutchan, FE Carr, JK
Citation: S. Tovanabutra et al., First CRF01_AE/B recombinant of HIV-1 is found in Thailand, AIDS, 15(8), 2001, pp. 1063-1065
Diverse BF recombinants have spread widely since the introduction of HIV-1into South America
Authors: Carr, JK Avila, M Carrillo, MG Salomon, H Hierholzer, J Watanaveeradej, V Pando, MA Negrete, M Russell, KL Sanchez, J Birx, DL Andrade, R Vinoles, J McCutchan, FE
Citation: Jk. Carr et al., Diverse BF recombinants have spread widely since the introduction of HIV-1into South America, AIDS, 15(15), 2001, pp. F41-F47
High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania
Authors: Hoelscher, M Kim, B Maboko, L Mhalu, F von Sonnenburg, F Birx, DL McCutchan, FE
Citation: M. Hoelscher et al., High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania, AIDS, 15(12), 2001, pp. 1461-1470
HIV-1 seroconversion in United States Army active duty personnel, 1985-1999
Authors: Renzullo, PO Sateren, WB Garner, RP Milazzo, MJ Birx, DL McNeil, JG
Citation: Po. Renzullo et al., HIV-1 seroconversion in United States Army active duty personnel, 1985-1999, AIDS, 15(12), 2001, pp. 1569-1574
The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon
Authors: Carr, JK Torimiro, JN Wolfe, ND Eitel, MN Kim, B Sanders-Buell, E Jagodzinski, LL Gotte, D Burke, DS Birx, DL McCutchan, FE
Citation: Jk. Carr et al., The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon, VIROLOGY, 286(1), 2001, pp. 168-181
Human skin Langerhans cells are targets of dengue virus infection
Authors: Wu, SJL Grouard-Vogel, G Sun, W Mascola, JR Brachtel, E Putvatana, R Louder, MK Filgueira, L Marovich, MA Wong, HK Blauvelt, A Murphy, GS Robb, ML Innes, BL Birx, DL Hayes, CG Frankel, SS
Citation: Sjl. Wu et al., Human skin Langerhans cells are targets of dengue virus infection, NAT MED, 6(7), 2000, pp. 816-820
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
Authors: Mascola, JR Stiegler, G VanCott, TC Katinger, H Carpenter, CB Hanson, CE Beary, H Hayes, D Frankel, SS Birx, DL Lewis, MG
Citation: Jr. Mascola et al., Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies, NAT MED, 6(2), 2000, pp. 207-210
Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand
Authors: McCutchan, FE Viputtigul, K De Souza, MS Carr, JK Markowitz, LE Buapunth, P McNeil, JG Robb, ML Nitayaphan, S Birx, DL Brown, AE
Citation: Fe. Mccutchan et al., Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand, AIDS RES H, 16(8), 2000, pp. 801-805
A comparative study of the impact of HIV infection on natural killer cell number and function in Thais and North Americans
Authors: De Souza, MS Karnasuta, C Brown, AE Markowitz, LE Nitayaphan, S Garner, RP McNeil, JG Birx, DL Cox, JH
Citation: Ms. De Souza et al., A comparative study of the impact of HIV infection on natural killer cell number and function in Thais and North Americans, AIDS RES H, 16(11), 2000, pp. 1061-1066
A flow cytometric method for measuring neutralization of HIV-1 subtype B and E primary isolates
Authors: Darden, JM Polonis, VR deSouza, MS Chantakulkij, S Brown, AE Birx, DL Pattanapanyasat, K
Citation: Jm. Darden et al., A flow cytometric method for measuring neutralization of HIV-1 subtype B and E primary isolates, CYTOMETRY, 40(2), 2000, pp. 141-150
HIV-1 suppression during acute scrub-typhus infection
Authors: Watt, G Kantipong, P de Souza, M Chanbancherd, P Jongsakul, K Ruangweerayud, R Loomis-Price, LD Polonis, V Myint, KS Birx, DL Brown, AE Krishna, S
Citation: G. Watt et al., HIV-1 suppression during acute scrub-typhus infection, LANCET, 356(9228), 2000, pp. 475-479
Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRFO1_AE) generated by the polymerase chain reaction
Authors: Salminen, MO Ehrenberg, PK Mascola, JR Dayhoff, DE Merling, R Blake, B Louder, M Hegerich, S Polonis, VR Birx, DL Robb, ML McCutchan, FE Michael, NL
Citation: Mo. Salminen et al., Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRFO1_AE) generated by the polymerase chain reaction, VIROLOGY, 278(1), 2000, pp. 103-110
Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers
Authors: Birx, DL Loomis-Price, LD Aronson, N Brundage, J Davis, C Deyton, L Garner, R Gordin, F Henry, D Holloway, W Kerkering, T Luskin-Hawk, R McNeil, J Michael, N Pierce, PF Poretz, D Ratto-Kim, S Renzullo, P Ruiz, N Sitz, K Smith, G Tacket, C Thompson, M Tramont, E Yangco, B Yarrish, R Redfield, RR
Citation: Dl. Birx et al., Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers, J INFEC DIS, 181(3), 2000, pp. 881-889
Antibody-dependent cellular cytotoxicity in HIV type 1-infected patients receiving VaxSyn, a recombinant gp160 envelope vaccine
Authors: Cox, JH Garner, RP Redfield, RR Aronson, NE Davis, C Ruiz, N Birx, DL
Citation: Jh. Cox et al., Antibody-dependent cellular cytotoxicity in HIV type 1-infected patients receiving VaxSyn, a recombinant gp160 envelope vaccine, AIDS RES H, 15(9), 1999, pp. 847-854
Characterization of subtype A HIV-1 from Africa by full genome sequencing
Authors: Carr, JK Laukkanen, T Salminen, MO Albert, J Alaeus, A Kim, B Sanders-Buell, E Birx, DL McCutchan, FE
Citation: Jk. Carr et al., Characterization of subtype A HIV-1 from Africa by full genome sequencing, AIDS, 13(14), 1999, pp. 1819-1826
Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope
Authors: VanCott, TC Mascola, JR Loomis-Price, LD Sinangil, F Zitomersky, N McNeil, J Robb, ML Birx, DL Barnett, S
Citation: Tc. Vancott et al., Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope, J VIROLOGY, 73(6), 1999, pp. 4640-4650
Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies
Authors: Mascola, JR Lewis, MG Stiegler, G Harris, D VanCott, TC Hayes, D Louder, MK Brown, CR Sapan, CV Frankel, SS Lu, YC Robb, ML Katinger, H Birx, DL
Citation: Jr. Mascola et al., Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies, J VIROLOGY, 73(5), 1999, pp. 4009-4018
Limited protection from a pathogenic chimeric simian-human immunodeficiency virus challenge following immunization with attenuated simian immunodeficiency virus
Authors: Lewis, MG Yalley-Ogunro, J Greenhouse, JJ Brennan, TP Jiang, JB VanCott, TC Lu, JC Eddy, GA Birx, DL
Citation: Mg. Lewis et al., Limited protection from a pathogenic chimeric simian-human immunodeficiency virus challenge following immunization with attenuated simian immunodeficiency virus, J VIROLOGY, 73(2), 1999, pp. 1262-1270
Proliferative responses to human immunodeficiency virus type 1 (HTV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controls
Authors: Sitz, KV Ratto-Kim, S Hodgkins, AS Robb, ML Birx, DL
Citation: Kv. Sitz et al., Proliferative responses to human immunodeficiency virus type 1 (HTV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controls, J INFEC DIS, 179(4), 1999, pp. 817-824
Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: Evaluation of the T cell proliferative response
Authors: Ratto-Kim, S Sitz, KV Garner, RP Kim, JH Davis, C Aronson, N Ruiz, N Tencer, K Redfield, RR Birx, DL
Citation: S. Ratto-kim et al., Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: Evaluation of the T cell proliferative response, J INFEC DIS, 179(2), 1999, pp. 337-344
Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type I highly exposed, persistently seronegative female sex workers in northern Thailand
Authors: Beyrer, C Artenstein, AW Rugpao, S Stephens, H VanCott, TC Robb, ML Rinkaew, M Birx, DL Khamboonruang, C Zimmerman, PA Nelson, KE Natpratan, C
Citation: C. Beyrer et al., Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type I highly exposed, persistently seronegative female sex workers in northern Thailand, J INFEC DIS, 179(1), 1999, pp. 59-67
Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion
Authors: Brodine, SK Shaffer, RA Starkey, MJ Tasker, SA Gilcrest, JL Louder, MK Barile, A VanCott, TC Vahey, MT McCutchan, FE Birx, DL Richman, DD Mascola, JR
Citation: Sk. Brodine et al., Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion, ANN INT MED, 131(7), 1999, pp. 502
Lymphocyte proliferation assay
Authors: Sitz, KV Birx, DL
Citation: Kv. Sitz et Dl. Birx, Lymphocyte proliferation assay, METH MOL M, 17, 1999, pp. 343-353
Risultati: 1-25 | 26-26